Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D de Valeriola

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Anticancer Research|November 1, 1994
Dose optimization of anthracyclinesD de Valeriola
Bulletin Du Cancer|January 1, 1989
[Diagnosis and treatment of unknown primary tumors]P Dodion, D De Valeriola
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1992
Anthracyclines active via the oral route: luxury or necessity?M J Piccart, D de Valeriola, E Tomiak
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1995
Regarding the dilemma of adjuvant therapy in postmenopausal patients with node-positive, estrogen receptor-positive breast cancer: are we better informed?J A Roy, D de Valeriola, M Piccart
Acta Clinica Belgica|January 1, 1988
Right atrial thrombus complicating Port-a-Cath systemJ M Grĕgoire, D De Valeriola, J L Vandenbossche
Drugs|September 1, 1997
Breast cancer therapies in development. A review of their pharmacology and clinical potentialD de Valeriola, A Awada, J A Roy, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1988
Phase I clinical trial of oral menogaril administered on three consecutive daysP Dodion, D de Valeriola, N Crespeigne, et al.
European Journal of Cancer & Clinical Oncology|February 1, 1989
Phase I clinical trial with carbetimerP Dodion, D de Valeriola, J J Body, et al.
Anti-Cancer Drugs|May 29, 2004
Prolonged schedule of temozolomide (Temodal) plus liposomal doxorubicin (Caelyx) in advanced solid cancersA Awada, T Gil, F Sales, et al.
Cancer|December 15, 1988
Six-year results of a multimodality treatment strategy for locally advanced breast cancerM J Piccart, D de Valeriola, R Paridaens, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Anticancer Research|November 1, 1994
Dose optimization of anthracyclinesD de Valeriola
Bulletin Du Cancer|January 1, 1989
[Diagnosis and treatment of unknown primary tumors]P Dodion, D De Valeriola
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1992
Anthracyclines active via the oral route: luxury or necessity?M J Piccart, D de Valeriola, E Tomiak
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1995
Regarding the dilemma of adjuvant therapy in postmenopausal patients with node-positive, estrogen receptor-positive breast cancer: are we better informed?J A Roy, D de Valeriola, M Piccart
Acta Clinica Belgica|January 1, 1988
Right atrial thrombus complicating Port-a-Cath systemJ M Grĕgoire, D De Valeriola, J L Vandenbossche
Drugs|September 1, 1997
Breast cancer therapies in development. A review of their pharmacology and clinical potentialD de Valeriola, A Awada, J A Roy, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1988
Phase I clinical trial of oral menogaril administered on three consecutive daysP Dodion, D de Valeriola, N Crespeigne, et al.
European Journal of Cancer & Clinical Oncology|February 1, 1989
Phase I clinical trial with carbetimerP Dodion, D de Valeriola, J J Body, et al.
Anti-Cancer Drugs|May 29, 2004
Prolonged schedule of temozolomide (Temodal) plus liposomal doxorubicin (Caelyx) in advanced solid cancersA Awada, T Gil, F Sales, et al.
Cancer|December 15, 1988
Six-year results of a multimodality treatment strategy for locally advanced breast cancerM J Piccart, D de Valeriola, R Paridaens, et al.
Pageof 2